Clinical Research Directory
Browse clinical research sites, groups, and studies.
Comparison of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for TNBC
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Summary
This study is an observational study that retrospectively collects data of triple-negative breast cancer patients who received neoadjuvant therapy. It compares the bpCR rate, apCR rate, and tpCR rate of patients treated with chemotherapy or immunotherapy, in order to analyze the efficacy and influencing factors of chemotherapy and immunotherapy in neoadjuvant therapy for triple-negative breast cancer.
Official title: Analysis of the Efficacy and Influencing Factors of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for Triple-Negative Breast Cancer
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
201
Start Date
2026-05-01
Completion Date
2027-05-01
Last Updated
2026-04-13
Healthy Volunteers
No
Conditions
Locations (1)
the First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China